In focus
WHO adds Oxford and Moderna Ebola vaccine candidates to DR Congo trial as outbreak becomes country's largest
Two new vaccine candidates, ChAdOx1 and mRNA-1469, will join the Tumaini trial in eastern DR Congo, marking the first evaluation of vaccines designed specifically for Bundibugyo virus during an outbreak. The country has recorded more than 10,500 confirmed cases and 5,126 deaths as of 1 November.
Read the story